Open AccessPathogenetic features of hypertension treatment in patients with concomitant abdominal obesity and underweight
Author(s) -
V. K. Tashchuk,
V. I. Denysiuk,
H. I. Hrebtii
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.2.70.2014.82
Subject(s) - medicine , atorvastatin , lisinopril , concomitant , amlodipine , underweight , cardiology , muscle hypertrophy , left ventricular hypertrophy , obesity , endocrinology , blood pressure , angiotensin converting enzyme , overweight
The study analyzed the performance of the structural remodeling of the myocardium and vascular endothelial function in patients with hypertension and varying body weight during the 3- and 6-month antihypertensive (lisinopril, amlodipine) and lipid-lowering (atorvastatin) therapy. Results of the study show that the smallest speaker regression of left ventricular hypertrophy and improvement of endothelial function of the vessels is determined in patients with deficiency of body weight.